Group 1 - Heartflow successfully raised $317 million by issuing 16.67 million shares at $19 each, exceeding the previously announced price range of $17-18 [1] - The company is set to list on the NASDAQ Global Select Market on Friday, with a market capitalization of $1.54 billion based on the final offering price [1] - The IPO comes at a time when the medical technology sector is facing challenges, as evidenced by recent underperforming IPOs in the industry [1] Group 2 - Heartflow's core technology platform creates personalized 3D models of patients' hearts, generating data on blood flow and plaque levels to facilitate the screening, diagnosis, and management of coronary artery disease [2] - For the quarter ending March 31, the company reported revenues of $37.2 million and a net loss of $32.3 million, compared to revenues of $26.8 million and a net loss of $20.9 million in the same period last year [2] - The IPO is underwritten by JPMorgan, Morgan Stanley, and Piper Sandler [2]
医疗科技公司Heartflow(HTFL.US)IPO定价超预期募资3.17亿 今晚登陆纳斯达克
智通财经网·2025-08-08 04:00